Mezieres-en-Drouais, France

Sylvie Lecoustey

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Debregeas Et Associes Pharma. Active years: 2018.

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sylvie Lecoustey: Innovator in Pharmaceutical Granules

Introduction

Sylvie Lecoustey is a notable inventor based in Mezieres-en-Drouais, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative granule formulations.

Latest Patents

Lecoustey holds a patent for gamma hydroxybutyric acid granules. This invention involves a granule that includes a solid core on which an active ingredient is supported. The active ingredient is selected from gamma-hydroxybutyric acid or one of its pharmaceutically acceptable salts. The granule also includes compounds that may generate gas evolvement and one or more diluents. Notably, the granule is coated with a membrane, and the solid core represents from 15% to 50% by weight based on the total weight of the granule. She has 1 patent to her name.

Career Highlights

Sylvie Lecoustey is associated with Debregeas Et Associes Pharma, where she continues to work on innovative pharmaceutical solutions. Her expertise in granule formulation has positioned her as a key player in her field.

Collaborations

Lecoustey collaborates with Pascal Suplie, contributing to the advancement of pharmaceutical technologies.

Conclusion

Sylvie Lecoustey's work in the development of gamma hydroxybutyric acid granules showcases her innovative spirit and dedication to improving pharmaceutical formulations. Her contributions are valuable to the industry and highlight the importance of research and development in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…